title: Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
authors.forename: L
authors.initials: L
authors.lastname: van Nimwegen-Campailla
authors.forename: N
authors.initials: N
authors.lastname: van Beveren
authors.forename: W
authors.initials: W
authors.lastname: Laan
authors.forename: W
authors.initials: W
authors.lastname: van den Brink
authors.forename: D
authors.initials: D
authors.lastname: Linszen
authors.forename: L
authors.initials: L
authors.lastname: de Haan
mesh_terms: D000342:Affective Symptoms / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008385:Marijuana Smoking; D055118:Medication Adherence; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine